With the analysis among 4,357 patents, we discovered top 433 key players by total patent application. Corixa Corp., OncoTherapy Science, Inc., Selecta Biosciences, Inc. are dominant in this area. They take 23.71% of the total patent filing.
Washington, United States
Patent: 589
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 361
Selecta Biosciences, Inc.
Massachusetts, United States
Patent: 83
International Institute of Cancer Immunology, Inc.
Massachusetts, United States
Patent: 64
Institut National de la Santé et de la Recherche Médicale
Hessen, Germany
Patent: 41
Washington, United States
Patent: 36
TheVax Genetics Vaccine Co., Ltd.
Taiwan Province, China
Patent: 35
Massachusetts, United States
Patent: 34
With the analysis among 187 patents, we discovered top 17 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Wuhan Huada Gino Biotechnology Co. Ltd., Agalimmune Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Wuhan Huada Gino Biotechnology Co. Ltd.
Hubei Sheng, China
Patent: 24
Tokyo-to, Japan
Patent: 15
North Carolina, United States
Patent: 11
Asylia Therapeutics, Inc.
Texas, United States
Patent: 7
California, United States
Patent: 3
IntelliStem Technologies, Inc.
With the analysis among related 975 patents applied in the last 5 years. We discover 271 most active companies in this area. The fast-growing OncoTherapy Science, Inc., The Board of Regents of The University of Texas System, BioNTech US, Inc. take 11.59% of patent filing during this period.
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 44
The Board of Regents of The University of Texas System
Texas, United States
Patent: 35
Massachusetts, United States
Patent: 34
Baylor College of Medicine
Texas, United States
Patent: 22
BEIJING DCTY® BIOTECH CO.,LTD
Beijing Shi, China
Patent: 20
Rubius Therapeutics, Inc.
Massachusetts, United States
Patent: 15
Tianjin Hengjia Biotechnology Development Co., Ltd.
Tianjin Shi, China
Patent: 15
Baylor Research Institute
Texas, United States
Patent: 14
With the analysis among related 975 patents in last 5 years, we discover 165 new entrants. BioNTech US, Inc., Good T Cells Inc, Rubius Therapeutics, Inc. are the most active new entrants in this area.
Massachusetts, United States
Patent: 34
Rubius Therapeutics, Inc.
Massachusetts, United States
Patent: 15
Tianjin Hengjia Biotechnology Development Co., Ltd.
Tianjin Shi, China
Patent: 15
Torque Therapeutics, Inc.
Massachusetts, United States
Patent: 11
Texas, United States
Patent: 11
Sichuan Sheng, China
Patent: 10
eTheRNA immunotherapies NV
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 9
Bolt Biotherapeutics, Inc.
California, United States
Patent: 9
With the analysis among 1,931 patents, we discovered top 176 universities and scientific research institutions by total patent application. Baylor College of Medicine, President & Fellows of Harvard College, Yale University are dominant in this area. They take 21.54% of the total patent filing.
Baylor College of Medicine
Texas, United States
Patent: 81
President & Fellows of Harvard College
Massachusetts, United States
Patent: 51
Connecticut, United States
Patent: 40
The Johns Hopkins University
New York, United States
Patent: 38
North Carolina, United States
Patent: 37
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 28
Nebraska, United States
Patent: 27
Tokyo-to, Japan
Patent: 27
École Polytechnique Fédérale de Lausanne
Vaud, Switzerland
Patent: 25